Exact Sciences [EXAS] vs Iqvia Holdings [IQV] Detailed Stock Comparison
Exact Sciences
NASDAQ
Loading...
Iqvia Holdings
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Exact Sciences wins in 5 metrics, Iqvia Holdings wins in 14 metrics, with 0 ties. Iqvia Holdings appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Exact Sciences | Iqvia Holdings | Better |
|---|---|---|---|
| P/E Ratio (TTM) | -10.15 | 29.90 | Exact Sciences |
| Price-to-Book Ratio | 4.35 | 6.08 | Exact Sciences |
| Debt-to-Equity Ratio | 102.73 | 272.12 | Exact Sciences |
| PEG Ratio | 0.11 | -1.35 | Iqvia Holdings |
| EV/EBITDA | 158.61 | 16.66 | Iqvia Holdings |
| Profit Margin (TTM) | -34.19% | 7.88% | Iqvia Holdings |
| Operating Margin (TTM) | 0.34% | 13.39% | Iqvia Holdings |
| EBITDA Margin (TTM) | 0.34% | 13.39% | Iqvia Holdings |
| Return on Equity | -35.51% | 19.79% | Iqvia Holdings |
| Return on Assets (TTM) | -1.39% | 5.16% | Iqvia Holdings |
| Free Cash Flow (TTM) | $74.55M | $2.11B | Iqvia Holdings |
| 1-Year Return | -18.79% | -10.57% | Iqvia Holdings |
| Price-to-Sales Ratio (TTM) | 3.65 | 2.24 | Iqvia Holdings |
| Enterprise Value | $12.42B | $48.69B | Iqvia Holdings |
| EV/Revenue Ratio | 4.22 | 3.10 | Iqvia Holdings |
| Gross Profit Margin (TTM) | 69.35% | 32.94% | Exact Sciences |
| Revenue per Share (TTM) | $16 | $89 | Iqvia Holdings |
| Earnings per Share (Diluted) | $-5.45 | $6.91 | Iqvia Holdings |
| Beta (Stock Volatility) | 1.24 | 1.33 | Exact Sciences |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Exact Sciences vs Iqvia Holdings Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Exact Sciences | 1.60% | 7.96% | 6.94% | 9.81% | 31.49% | 1.23% |
| Iqvia Holdings | -0.78% | 13.45% | 9.24% | 26.20% | 33.99% | 5.07% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Exact Sciences | -18.79% | 89.88% | -44.22% | 621.28% | 548.99% | 2,738.92% |
| Iqvia Holdings | -10.57% | 18.23% | 24.59% | 186.46% | 383.65% | 383.65% |
News Based Sentiment: Exact Sciences vs Iqvia Holdings
Exact Sciences
News based Sentiment: MIXED
Exact Sciences reported strong first-quarter revenue growth, but simultaneously lowered its full-year guidance. This combination of positive and negative developments creates a mixed investment narrative, suggesting both opportunities and potential challenges for investors.
Iqvia Holdings
News based Sentiment: POSITIVE
IQVIA delivered a strong Q2 performance, raised its full-year guidance, and saw increased analyst and institutional confidence. While insider selling is a minor concern, the overall narrative for the month is positive, suggesting continued growth and investment potential.
Performance & Financial Health Analysis: Exact Sciences vs Iqvia Holdings
| Metric | EXAS | IQV |
|---|---|---|
| Market Information | ||
| Market Cap | $10.74B | $36.03B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 2,085,300 | 1,417,620 |
| 90 Day Avg. Volume | 2,552,067 | 1,292,383 |
| Last Close | $57.63 | $205.02 |
| 52 Week Range | $38.81 - $72.83 | $134.65 - $237.34 |
| % from 52W High | -20.87% | -13.62% |
| All-Time High | $159.54 (Jan 25, 2021) | $285.61 (Dec 27, 2021) |
| % from All-Time High | -63.88% | -28.22% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.16% | 0.05% |
| Quarterly Earnings Growth | 0.16% | -0.27% |
| Financial Health | ||
| Profit Margin (TTM) | -0.34% | 0.08% |
| Operating Margin (TTM) | 0.00% | 0.13% |
| Return on Equity (TTM) | -0.36% | 0.20% |
| Debt to Equity (MRQ) | 102.73 | 272.12 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $13.05 | $33.99 |
| Cash per Share (MRQ) | $4.53 | $12.87 |
| Operating Cash Flow (TTM) | $305.61M | $2.62B |
| Levered Free Cash Flow (TTM) | $140.26M | $2.45B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | N/A |
Valuation & Enterprise Metrics Analysis: Exact Sciences vs Iqvia Holdings
| Metric | EXAS | IQV |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | -10.15 | 29.90 |
| Forward P/E | -166.82 | 17.12 |
| PEG Ratio | 0.11 | -1.35 |
| Price to Sales (TTM) | 3.65 | 2.24 |
| Price to Book (MRQ) | 4.35 | 6.08 |
| Market Capitalization | ||
| Market Capitalization | $10.74B | $36.03B |
| Enterprise Value | $12.42B | $48.69B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 4.22 | 3.10 |
| Enterprise to EBITDA | 158.61 | 16.66 |
| Risk & Other Metrics | ||
| Beta | 1.24 | 1.33 |
| Book Value per Share (MRQ) | $13.05 | $33.99 |
Financial Statements Comparison: Exact Sciences vs Iqvia Holdings
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | EXAS | IQV |
|---|---|---|
| Revenue/Sales | $706.79M | $4.02B |
| Cost of Goods Sold | $206.24M | $2.69B |
| Gross Profit | $500.55M | $1.32B |
| Research & Development | $105.31M | N/A |
| Operating Income (EBIT) | $-89.76M | $538.00M |
| EBITDA | $-36.86M | $813.00M |
| Pre-Tax Income | $-100.99M | $323.00M |
| Income Tax | $224,000 | $56.00M |
| Net Income (Profit) | $-101.22M | $266.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | EXAS | IQV |
|---|---|---|
| Cash & Equivalents | $347.13M | $2.04B |
| Total Current Assets | $1.37B | $6.35B |
| Total Current Liabilities | $502.47M | $7.57B |
| Long-Term Debt | $2.49B | $14.39B |
| Total Shareholders Equity | $2.40B | $5.79B |
| Retained Earnings | $-4.60B | $6.58B |
| Property, Plant & Equipment | $126.66M | $816.00M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | EXAS | IQV |
|---|---|---|
| Operating Cash Flow | $-36.98M | $459.00M |
| Capital Expenditures | $-31.17M | $-151.00M |
| Free Cash Flow | $-365,000 | $292.00M |
| Debt Repayment | $-249.17M | $-1.74B |
| Common Stock Repurchase | N/A | $-657.00M |
Short Interest & Institutional Ownership Analysis
| Metric | EXAS | IQV |
|---|---|---|
| Shares Short | 8.09M | 4.68M |
| Short Ratio | 2.76 | 3.92 |
| Short % of Float | 0.05% | 0.03% |
| Average Daily Volume (10 Day) | 2,085,300 | 1,417,620 |
| Average Daily Volume (90 Day) | 2,552,067 | 1,292,383 |
| Shares Outstanding | 185.62M | 176.10M |
| Float Shares | 187.46M | 161.46M |
| % Held by Insiders | 0.01% | 0.01% |
| % Held by Institutions | 0.96% | 1.02% |
Dividend Analysis & Yield Comparison: Exact Sciences vs Iqvia Holdings
| Metric | EXAS | IQV |
|---|---|---|
| Last 12-Month Dividend | N/A | N/A |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | N/A |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | N/A |
| Ex-Dividend Date | N/A | N/A |